BindingDB

The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 748K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Donate Now

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

Advanced Search

9 articles for thisTarget

The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Discovery of CRN04894: A Novel Potent Selective MC2R Antagonist.EBI
Crinetics Pharmaceuticals
Discovery of Paltusotine (CRN00808), a Potent, Selective, and Orally Bioavailable Non-peptide SST2 Agonist.EBI
Crinetics Pharmaceuticals
Discovery of 4-(3-aminopyrrolidinyl)-3-aryl-5-(benzimidazol-2-yl)-pyridines as potent and selective SST5 agonists for the treatment of congenital hyperinsulinism.EBI
Crinetics Pharmaceuticals
Discovery of substituted 3H-pyrido[2,3-d]pyrimidin-4-ones as potent, biased, and orally bioavailable sst2 agonist.EBI
Crinetics Pharmaceuticals
Heterocyclic compounds as kinase inhibitorsBDB
Nuvation Bio
OXA-Diazaspiro compounds having activity against painBDB
Esteve Pharmaceuticals
1,3-dihydroxy-phenyl derivatives useful as immunomodulatorsBDB
Bristol-Meyers Squibb
Protein kinase inhibitors (variants), use thereof in treating oncological diseases and a pharmaceutical composition based thereonBDB
Obshchestvo S Ogranichennoy Otvetstvennostyou “Fusion Pharma”
PET Imaging agentsBDB
Novartis